MXBUX
Price
$9.43
Change
+$0.04 (+0.43%)
Updated
Jan 17 closing price
Net Assets
1.73B
VIMSX
Price
$74.75
Change
+$0.37 (+0.50%)
Updated
Jan 17 closing price
Net Assets
176.87B
Ad is loading...

MXBUX vs VIMSX

Header iconMXBUX vs VIMSX Comparison
Open Charts MXBUX vs VIMSXBanner chart's image
Empower S&P Mid Cap 400® Index L
Price$9.43
Change+$0.04 (+0.43%)
VolumeN/A
Net Assets1.73B
Vanguard Mid Cap Index Investor
Price$74.75
Change+$0.37 (+0.50%)
VolumeN/A
Net Assets176.87B
MXBUX vs VIMSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MXBUX vs. VIMSX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MXBUX is a Buy and VIMSX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 177B vs. MXBUX (1.73B). MXBUX pays higher dividends than VIMSX: MXBUX (2.91) vs VIMSX (1.38). MXBUX was incepted earlier than VIMSX: MXBUX (8 years) vs VIMSX (27 years). MXBUX is a more actively managed with annual turnover of: 24.00 vs. VIMSX (13.00). MXBUX has a lower initial minimum investment than VIMSX: MXBUX (0) vs VIMSX (3000). VIMSX annual gain was more profitable for investors over the last year : 20.80 vs. MXBUX (14.84). VIMSX return over 5 years is better than : 50.59 vs. MXBUX (9.83).
MXBUXVIMSXMXBUX / VIMSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years27 years-
Gain YTD3.7403.719101%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.73B177B1%
Annual Yield % from dividends2.911.38210%
Returns for 1 year14.8420.8071%
Returns for 3 years-1.8115.25-12%
Returns for 5 years9.8350.5919%
Returns for 10 yearsN/A130.18-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SF113.882.04
+1.82%
Stifel Financial Corp
JZXN1.57N/A
N/A
Jiuzi Holdings Inc.
UNH509.76-0.83
-0.16%
Unitedhealth Group
MYGN12.39-0.13
-1.04%
Myriad Genetics
KPTI0.66-0.04
-5.47%
Karyopharm Therapeutics